Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03109184 · ClinicalTrials.gov registry record · NA

Violence Prevention for Middle School Boys

A NA study of Intimate Partner Violence, sponsored by Northeastern University.

Completed
Registry status
NA
Development phase
119
Enrollment target
1
Study location

NCT03109184 is a NA study of Intimate Partner Violence that has completed, run by Northeastern University. The registered enrollment target is 119 participants, below the 349-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03109184, a NA study of Intimate Partner Violence, has completed, sponsored by Northeastern University.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target
1
Study location

Study Summary

This study will develop and test a web-based intervention to enhance emotion regulation skills and parent-son relationship communication to decrease adolescent boys' risk for dating violence involvement as well as attitudes supporting relationship aggression.

Conditions Studied

Interventions

  • BEHAVIORAL Project STRONG

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2015-01-01
Est. Completion 2018-12-31
Phase NA

Sponsor

Northeastern University

39 total trials

What the Registry Record Tells You About NCT03109184

The ClinicalTrials.gov registry entry for NCT03109184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 349-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (66% lower). The listed sponsor is Northeastern University, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intimate Partner Violence appearing as the primary indexed condition, and to 1 intervention - of which Project STRONG is the first listed.

NCT03109184 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT03109184 about?

NCT03109184 is a clinical study titled "Violence Prevention for Middle School Boys". This study will develop and test a web-based intervention to enhance emotion regulation skills and parent-son relationship communication to decrease adolescent boys' risk for dating violence involvement as well as attitudes supporting relationship aggression.

What is the current status of trial NCT03109184?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2015-01-01. Estimated completion is 2018-12-31.

What conditions does trial NCT03109184 study?

This clinical trial studies the following conditions: Intimate Partner Violence.

What interventions are being tested in trial NCT03109184?

The interventions under investigation include: Project STRONG (BEHAVIORAL).

Who is sponsoring clinical trial NCT03109184?

This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03109184 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intimate Partner Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.